Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2019-02-01Clinical Trial Update: Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)
Post-authorization long-term safety surveillance study of Kanarb® (fimasartan) in essential hypertension has completed with results posted.